SHS Newsletter

Healthcare Specialist SHS Capital agreed to sell its portfolio company PathoQuest, a specialist in NGS-based quality control assays for biopharmaceuticals, to the strategic buyer Charles River Laboratories, a leading global provider of products and services that support drug discovery and non-clinical development. Founded in Paris, PathoQuest has established itself as a reference player in NGS-based […]

Tübingen / Kaltenkirchen / Illmensee, 17 December 2025 SHS Capital invests through its SHS VI fund in a consortium of four German medical technology companies focused on endoscopy systems, comprising EMOS Technology, InnoView, ILO electronic and Micon. The Endoscopy Group develops and manufactures high-quality, reusable flexible, rigid and semi-flexible endoscopes as well as camera and […]

We are delighted to support the Stuttgart parents’ group of the organization “Mein Herz lacht” with our donation this year. This non-profit organization is dedicated to strengthening and supporting parents of children with disabilities. As a self-help community, “Mein Herz lacht e.V.” has been driving real change for families with children with disabilities since 2019, […]

Tübingen, 25 November 2025 SHS Capital, together with its portfolio company MTR, has acquired Curatec Services GmbH, an established provider of innovative electrical stimulation devices. The aim of the transaction is to secure Curatec’s proven expertise and product range for the long term, expand it within the MTR platform, and ensure that patients throughout Germany […]

We’re delighted to see the regional press Schwäbische highlighting our recent partnership with Ackermann. Another great example of how SHS Capital supports entrepreneurs when succession within the family isn’t an option. Together, we’ve created a solution that safeguards the company’s legacy, drives future growth, and keeps its values at the heart of the business. As […]

AMW GmbH, a pharmaceutical company specialising in biodegradable implants, has initiated a research and development project aimed at increasing the efficiency of formulation development through the use of AI. The project is being scientifically supported by the research group of Prof. Dr. Olivia Merkel (LMU Munich), an expert in the field of drug delivery. The […]

A study conducted at the University of Helsinki and Helsinki University Hospital has evaluated the performance of the MESI mTABLET TBI toe pressure photoplethysmography device against a stationary laser Doppler flow meter, the current gold standard for assessing superficial microvessels. The University of Helsinki study shows that the MESI mTABLET TBI demonstrates high concordance with […]

We are delighted that the new product RoTecPSMA® from our portfolio company ROTOP has received marketing authorisation in the UK. RoTecPSMA® is a diagnostic kit that uses technetium-99m and has been specially developed for SPECT imaging in prostate cancer patients. It is the first PSMA SPECT tracer to be approved in a European country. It […]

At its 181st meeting in March 2025, the European Pharmacopoeia Commission (EPC) adopted a new general chapter entitled ” High-throughput sequencing for the detection of viral extraneous agents (2.6.41)”. The new chapter will be published in edition 12.2 of the European Pharmacopoeia (Ph. Eur.) in October 2025 and will enter into force on 1 April […]

SHS Capital recently hosted another Portfolio Workshop, bringing together executives from SHS portfolio companies to discuss how to promote effective leadership, scale businesses efficiently and manage growth in dynamic markets. Under the expert moderation of Thalia Ucksche, Bernhard Stieger and Alexander Liolios from Spencer Stuart, the workshop focused on the changing requirements of scaling companies […]

The annual SHS Investors’ Day took place again this year in Tübingen. Investors, portfolio representatives, senior advisors, healthcare experts and other valued guests were warmly welcomed at the Hotel Krone in the heart of Tübingen. The day offered engaging presentations on healthcare topics and an outlook on economic development and medical innovations over the coming […]

Rietheim-Weilheim / Tübingen, 8 July 2025 Healthcare investor SHS Capital has acquired a majority stake in Ackermann Instrumente GmbH. The investment aims to expand Ackermann’s core business and, through partnerships and acquisitions of additional companies, build a leading, globally positioned MedTech group. Ackermann Instrumente GmbH, headquartered near Tuttlingen, is a leading manufacturer of high-quality surgical […]